1477
COM:OCUMENSION
Ocumension Therapeutics
- Stock
Last Close
5.19
25/11 08:08
Market Cap
4.65B
Beta: -
Volume Today
1.48M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '21 | Jun '21 | Sep '21 | Dec '21 | Mar '22 | Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -34.80M - | -34.80M 0% | -95.19M 173.50% | -95.19M 0% | -96.33M 1.20% | -96.33M 0% | -104.99M 8.98% | -104.99M 0% | -104.20M 0.75% | -104.20M 0% | -85.69M 17.76% | -85.69M 0% | |
depreciation and amortization | 1.91M - | 1.91M 0% | 5.04M 164.68% | 5.04M 0% | 9.08M 80.04% | 9.08M 0% | 11.15M 22.77% | 11.15M 0% | 14.46M 29.73% | 14.46M 0% | |||
deferred income tax | -41.57M - | -41.63M 0.13% | -163.20M 292.05% | -45.95M 71.85% | -109.67M 138.69% | ||||||||
stock based compensation | 37.79M - | 37.79M 0% | 56.27M 48.90% | 56.27M 0% | 57.91M 2.92% | 57.91M 0% | 51.49M 11.09% | 51.49M 0% | 41.25M 19.87% | 41.25M 0% | 28.61M 30.65% | 28.61M 0% | |
change in working capital | -6.99M - | -6.99M 0% | -9.56M 36.79% | -9.56M 0% | -30.49M 218.75% | -16.34M 46.42% | -9.86M 39.65% | -9.86M 0% | 4.69M 147.58% | 4.69M 0% | |||
accounts receivables | -7.35M - | -7.35M 0% | -8.22M 11.86% | -8.22M 0% | -6.92M 15.83% | -6.92M 0% | -9.72M 40.41% | -9.72M 0% | 9.54M 198.19% | 9.54M 0% | |||
inventory | 359K - | 359K 0% | -1.34M 473.82% | -1.34M 0% | -9.41M 601.53% | -9.41M 0% | -141K 98.50% | -141K 0% | -4.85M 3,340.78% | -4.85M 0% | |||
accounts payables | -42.35M - | -13.59M - | |||||||||||
other working capital | -14.15M - | 42.35M - | 13.59M - | ||||||||||
other non cash items | -56.40M - | -56.40M 0% | 3.52M 106.24% | 3.52M 0% | 35.05M 895.51% | 62.47M 78.25% | 18.29M 70.72% | 139.87M 664.56% | 30.93M 77.89% | 94.65M 206.03% | 57.08M 39.69% | 57.08M 0% | |
net cash provided by operating activities | -58.50M - | -58.50M 0% | -39.92M 31.76% | -39.92M 0% | -24.78M 37.92% | -24.78M 0% | -75.54M 204.81% | -75.54M 0% | -58.81M 22.15% | -58.81M 0% | |||
investments in property plant and equipment | -64.91M - | -64.91M 0% | -32.78M 49.50% | -32.78M 0% | -30.16M 8.00% | -30.16M 0% | -27.75M 7.98% | -27.75M 0% | -12.47M 55.06% | -12.47M 0% | |||
acquisitions net | -1 - | 406.41M - | |||||||||||
purchases of investments | -2.19B - | -711.26M - | |||||||||||
sales maturities of investments | 1.98B - | 304.85M - | |||||||||||
other investing activites | -89.38M - | -89.38M 0% | -485.58M 443.29% | -485.58M 0% | 278.06M 157.26% | 278.06M 0% | -105.58M 137.97% | 105.01M 199.46% | -247.09M 335.29% | -247.09M 0% | |||
net cash used for investing activites | -154.29M - | -154.29M 0% | -518.36M 235.97% | -518.36M 0% | 247.90M 147.82% | 247.90M 0% | -133.33M 153.78% | -133.33M 0% | -259.56M 94.67% | -259.56M 0% | |||
debt repayment | -2.05M - | ||||||||||||
common stock issued | 13.05M - | 5.19M - | |||||||||||
common stock repurchased | -694K - | -694K 0% | -5.36M 672.69% | -5.36M 0% | -138.50K 97.42% | -138.50K 0% | |||||||
dividends paid | |||||||||||||
other financing activites | 330.48M - | 330.48M 0% | 4.64M 98.60% | 4.64M 0% | -1.21M 126.16% | -6.58M 442.09% | 2.10M 131.98% | -10.95M 620.52% | -1.96M 82.12% | -5.10M 160.77% | |||
net cash used provided by financing activities | 330.48M - | 330.48M 0% | 3.94M 98.81% | 3.94M 0% | -6.58M 266.76% | -6.58M 0% | 1.96M 129.88% | 1.96M 0% | -1.96M 199.62% | -1.96M 0% | |||
effect of forex changes on cash | -5.31M - | -5.31M 0% | -12.60M 137.20% | -12.60M 0% | 6.99M 155.51% | 6.99M 0% | 5.79M 17.21% | 5.79M 0% | 3.82M 33.98% | 3.82M 0% | |||
net change in cash | 112.39M - | 112.39M 0% | -566.93M 604.46% | -566.93M 0% | 223.54M 139.43% | 223.54M 0% | -201.12M 189.97% | -503.21M 150.20% | -316.50M 37.10% | -737.69M 133.08% | |||
cash at beginning of period | 2.15B - | 2.26B 5.24% | 1.35B - | 1.57B 16.57% | 1.85B 17.41% | 1.34B - | |||||||
cash at end of period | 112.39M - | 2.26B 1,910.13% | 1.69B 25.10% | -566.93M 133.50% | 223.54M 139.43% | 1.57B 603.37% | 1.37B 12.79% | 1.34B 2.07% | -316.50M 123.57% | 605.16M 291.20% | |||
operating cash flow | -58.50M - | -58.50M 0% | -39.92M 31.76% | -39.92M 0% | -24.78M 37.92% | -24.78M 0% | -75.54M 204.81% | -75.54M 0% | -58.81M 22.15% | -58.81M 0% | |||
capital expenditure | -64.91M - | -64.91M 0% | -32.78M 49.50% | -32.78M 0% | -30.16M 8.00% | -30.16M 0% | -27.75M 7.98% | -27.75M 0% | -12.47M 55.06% | -12.47M 0% | |||
free cash flow | -123.41M - | -123.41M 0% | -72.70M 41.09% | -72.70M 0% | -54.94M 24.43% | -54.94M 0% | -103.29M 88.01% | -103.29M 0% | -71.28M 30.99% | -71.28M 0% |
All numbers in HKD (except ratios and percentages)